文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

循环肿瘤细胞的生存机制及其对癌症治疗的意义。

Survival mechanisms of circulating tumor cells and their implications for cancer treatment.

机构信息

Division of Abdominal Cancer, Department of Medical Oncology, Cancer Center and Laboratory of Molecular Targeted Therapy in Oncology, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.

出版信息

Cancer Metastasis Rev. 2024 Sep;43(3):941-957. doi: 10.1007/s10555-024-10178-7. Epub 2024 Mar 4.


DOI:10.1007/s10555-024-10178-7
PMID:38436892
Abstract

Metastasis remains the principal trigger for relapse and mortality across diverse cancer types. Circulating tumor cells (CTCs), which originate from the primary tumor or its metastatic sites, traverse the vascular system, serving as precursors in cancer recurrence and metastasis. Nevertheless, before CTCs can establish themselves in the distant parenchyma, they must overcome significant challenges present within the circulatory system, including hydrodynamic shear stress (HSS), oxidative damage, anoikis, and immune surveillance. Recently, there has been a growing body of compelling evidence suggesting that a specific subset of CTCs can persist within the bloodstream, but the precise mechanisms of their survival remain largely elusive. This review aims to present an outline of the survival challenges encountered by CTCs and to summarize the recent advancements in understanding the underlying survival mechanisms, suggesting their implications for cancer treatment.

摘要

转移仍然是各种癌症类型复发和死亡的主要诱因。循环肿瘤细胞(CTCs)来源于原发性肿瘤或其转移部位,它们穿过血管系统,成为癌症复发和转移的前体。然而,在 CTCs 能够在远处实质中定居之前,它们必须克服循环系统中存在的重大挑战,包括流体切应力(HSS)、氧化损伤、失巢凋亡和免疫监视。最近,越来越多的令人信服的证据表明,特定亚群的 CTCs 可以在血液中持续存在,但它们的生存确切机制在很大程度上仍难以捉摸。本综述旨在概述 CTCs 所遇到的生存挑战,并总结对其潜在生存机制的最新理解,提示它们对癌症治疗的影响。

相似文献

[1]
Survival mechanisms of circulating tumor cells and their implications for cancer treatment.

Cancer Metastasis Rev. 2024-9

[2]
Survival Mechanisms and Influence Factors of Circulating Tumor Cells.

Biomed Res Int. 2018-11-1

[3]
Shear stress activates ATOH8 via autocrine VEGF promoting glycolysis dependent-survival of colorectal cancer cells in the circulation.

J Exp Clin Cancer Res. 2020-1-30

[4]
Intravascular Survival and Extravasation of Tumor Cells.

Cancer Cell. 2017-9-11

[5]
Squeezing through the microcirculation: survival adaptations of circulating tumour cells to seed metastasis.

Br J Cancer. 2021-1

[6]
Distinguishing high-metastasis-potential circulating tumor cells through fluidic shear stress in a bloodstream-like microfluidic circulatory system.

Oncogene. 2024-7

[7]
Cellular Mechanisms of Circulating Tumor Cells During Breast Cancer Metastasis.

Int J Mol Sci. 2020-7-17

[8]
Circulating tumor cell-blood cell crosstalk: Biology and clinical relevance.

Cell Rep. 2022-8-30

[9]
Clinical and biological significance of circulating tumor cells in cancer.

Mol Oncol. 2016-3

[10]
S-Nitrosocaptopril prevents cancer metastasis in vivo by creating the hostile bloodstream microenvironment against circulating tumor cells.

Pharmacol Res. 2018-10-23

引用本文的文献

[1]
Pathogenetic development, diagnosis and clinical therapeutic approaches for liver metastasis from colorectal cancer (Review).

Int J Oncol. 2025-3

[2]
Tumor dormancy and relapse: understanding the molecular mechanisms of cancer recurrence.

Mil Med Res. 2025-2-11

[3]
Tumor microbiome: roles in tumor initiation, progression, and therapy.

Mol Biomed. 2025-2-8

[4]
Identification of anoikis-related molecular patterns and the novel risk model to predict prognosis, tumor microenvironment infiltration and immunotherapy response in bladder cancer.

Front Immunol. 2024-11-27

[5]
LncRNA FAISL Inhibits Calpain 2-Mediated Proteolysis of FAK to Promote Progression and Metastasis of Triple Negative Breast Cancer.

Adv Sci (Weinh). 2024-11

[6]
Synthesis, characterization and biological research of novel 2-(quinoline-4-carbonyl)hydrazide-acrylamide hybrids as potential anticancer agents on MCF-7 breast carcinoma cells by targeting EGFR-TK.

RSC Adv. 2024-7-26

本文引用的文献

[1]
Association of survivin positive circulating tumor cell levels with immune escape and prognosis of osteosarcoma.

J Cancer Res Clin Oncol. 2023-11

[2]
Emerging phagocytosis checkpoints in cancer immunotherapy.

Signal Transduct Target Ther. 2023-3-7

[3]
Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance.

Cancer Cell. 2023-2-13

[4]
Circulating tumor cells PD-L1 expression detection and correlation of therapeutic efficacy of immune checkpoint inhibition in advanced non-small-cell lung cancer.

Thorac Cancer. 2023-2

[5]
Engineered drug-loaded cellular membrane nanovesicles for efficient treatment of postsurgical cancer recurrence and metastasis.

Sci Adv. 2022-12-9

[6]
CPT1A promotes anoikis resistance in esophageal squamous cell carcinoma via redox homeostasis.

Redox Biol. 2022-12

[7]
Shear stress enhances anoikis resistance of cancer cells through ROS and NO suppressed degeneration of Caveolin-1.

Free Radic Biol Med. 2022-11-20

[8]
Fluid shear stress facilitates prostate cancer metastasis through Piezo1-Src-YAP axis.

Life Sci. 2022-11-1

[9]
Role of CD155/TIGIT in Digestive Cancers: Promising Cancer Target for Immunotherapy.

Front Oncol. 2022-3-30

[10]
Immune Checkpoint FGL1 Expression of Circulating Tumor Cells Is Associated With Poor Survival in Curatively Resected Hepatocellular Carcinoma.

Front Oncol. 2022-2-22

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索